"CORONAVIRUS INFO: Appointment days and times at this location may currently be modified. Penn Medicine Lancaster General Health is dedicated to the health and safety of patients, their families, and our staff. Check our website for updated hours."

During the past decade, Lancaster General Ann B Barshinger Cancer Institute conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lancaster General Ann B Barshinger Cancer Institute" #1 sponsor was "National Cancer Institute (NCI)" with 7 trials, followed by "NRG Oncology" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Canadian Cancer Trials Group" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lancaster General Ann B Barshinger Cancer Institute" #1 collaborator was "NRG Oncology" with 7 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "Eastern Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Lancaster General Ann B Barshinger Cancer Institute" are "Colorectal Carcinoma" (2 trials), "Endometrial Endometrioid Adenocarcinoma" (2 trials), "Ovarian Carcinoma" (2 trials), "Recurrent Ovarian Carcinoma" (2 trials) and "Advanced Cancer" (1 trials). Many other conditions were trialed in "Lancaster General Ann B Barshinger Cancer Institute" in a lesser frequency.

Most popular intervention types in "Lancaster General Ann B Barshinger Cancer Institute" are "Other" (10 trials), "Drug" (9 trials), "Procedure" (8 trials), "Biological" (7 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (7 trials), "Computed Tomography" (5 trials), "Questionnaire Administration" (5 trials), "Atezolizumab" (3 trials) and "Biospecimen Collection" (3 trials). Other intervention names were less common.

The vast majority of trials in "Lancaster General Ann B Barshinger Cancer Institute" are 8 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Lancaster General Ann B Barshinger Cancer Institute". undefined are not yet recruiting, 3 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Lancaster General Ann B Barshinger Cancer Institute, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lancaster General Ann B Barshinger Cancer Institute, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".